Munoz J M, Gorman C A, Elveback L R, Wentz J R
Arch Intern Med. 1978 Jun;138(6):944-7.
The incidence of malignancy among patients with Graves' disease who were residents of one Minnesota county was examined in 342 patients between 1935 and 1967. During 4,736 person-years of observation, 32 malignancies were diagnosed; 24 cases were expected and the difference is not significant. Four cases of breast carcinoma were found vs five expected. Other tumor sites were cervix (five), uterus (two), rectosigmoid colon (three), stomach (two), larynx (two), and lung (two). There were three cases of leukemia, and in nine other sites one cancer each was recorded. There was a slightly higher than expected incidence of malignancy in patients who had received 131I therapy; this finding requires further study in a larger patient population. Among patients who received thyroid hormone, the observed incidence of breast cancer was not significantly different from the expected incidence in our population.
1935年至1967年间,对明尼苏达州一个县的342例格雷夫斯病患者的恶性肿瘤发病率进行了检查。在4736人年的观察期内,诊断出32例恶性肿瘤;预期为24例,差异无统计学意义。发现4例乳腺癌,预期为5例。其他肿瘤部位包括子宫颈(5例)、子宫(2例)、直肠乙状结肠(3例)、胃(2例)、喉(2例)和肺(2例)。有3例白血病,在其他9个部位各记录1例癌症。接受131I治疗的患者恶性肿瘤发病率略高于预期;这一发现需要在更大的患者群体中进一步研究。在接受甲状腺激素治疗的患者中,观察到的乳腺癌发病率与我们人群中的预期发病率无显著差异。